Ahmet Gürakar
- Hepatology top 0.5%
- Liver Disease and Transplantation 77
- Hepatitis C virus research 36
- Hepatocellular Carcinoma Treatment and Prognosis 22
- Transplantation top 2%
- Renal Transplantation Outcomes and Treatments 12
- Epidemiology top 2%
- Liver Disease Diagnosis and Treatment 77
- Hepatitis B Virus Studies 21
- Surgery top 2%
- Organ Transplantation Techniques and Outcomes 66
-
- Gallbladder and Bile Duct Disorders 12
- Co-authors
- Sharad SharmaNicolas JabbourAndrew M. CameronZhiping LiBenjamin PhilosopheJoseph M. HermanAmin FiroozmandBehnam Saberi
- Journals
- SHILAP Revista de lepidopterología (1 paper)Gastroenterology (4 papers)Hepatology (3 papers)
- Partner nations
- United StatesTürkiyeSaudi Arabia
In The Last Decade
Ahmet Gürakar
162 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 109
- Hepatology 1.5k
- Transplantation 199
- Epidemiology 1.1k
- Surgery 1.2k
- Pathology and Forensic Medicine 324
Countries citing papers authored by Ahmet Gürakar
This map shows the geographic impact of Ahmet Gürakar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ahmet Gürakar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ahmet Gürakar more than expected).
Fields of papers citing papers by Ahmet Gürakar
This network shows the impact of papers produced by Ahmet Gürakar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ahmet Gürakar. The network helps show where Ahmet Gürakar may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ahmet Gürakar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 0 | |
| 6 | 2023 | 10 | |
| 7 | 2023 | 4 | |
| 8 | 2022 | 2 | |
| 9 | 2020 | 35 | |
| 10 | 2020 | 4 | |
| 11 | 2016 | 31 | |
| 12 | 2016 | 4 | |
| 13 | 2016 | 45 | |
| 14 | 2016 | 10 | |
| 15 | 2015 | 29 | |
| 16 | 2015 | 2 | |
| 17 | 2013 | 40 | |
| 18 | 2010 | 17 | |
| 19 | Hepatitis C and the controversies it creates relative to liver transplantation and autoimmune hepatitis. | 1996 | 4 |
| 20 | Prophylactic alpha-interferon therapy following liver transplantation: does it prevent allograft infection? | 1994 | 2 |
About Ahmet Gürakar
Ahmet Gürakar is a scholar working on Hepatology, Transplantation and Epidemiology, having authored 174 papers that have together received 2.8k indexed citations. Recurring topics across this work include Liver Disease and Transplantation (77 papers), Liver Disease Diagnosis and Treatment (77 papers), Organ Transplantation Techniques and Outcomes (66 papers), Hepatitis C virus research (36 papers), Hepatocellular Carcinoma Treatment and Prognosis (22 papers), Hepatitis B Virus Studies (21 papers), Renal Transplantation Outcomes and Treatments (12 papers) and Gallbladder and Bile Duct Disorders (12 papers). The work is most often cited by research in Hepatology (1.5k citations), Transplantation (199 citations) and Epidemiology (1.1k citations). Ahmet Gürakar has collaborated with scholars based in United States, Türkiye and Saudi Arabia. Frequent co-authors include Sharad Sharma, Nicolas Jabbour, Andrew M. Cameron, Zhiping Li, Benjamin Philosophe, Joseph M. Herman, Amin Firoozmand, Behnam Saberi, Jacqueline Garonzik‐Wang and Dorry L. Segev. Their work appears in journals such as SHILAP Revista de lepidopterología, Gastroenterology and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.